NOVELLO, Salvatore
NOVELLO, Salvatore
Dipartimento di Scienze Chimiche e Farmaceutiche (attivo dal 01/01/2012 al 31/12/2022)
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
2017 Longo, Francesco; Mercatelli, Daniela; Novello, Salvatore; Arcuri, Ludovico; Brugnoli, Alberto; Vincenzi, Fabrizio; Russo, Isabella; Berti, Giulia; Mabrouk, Omar Sharif; Kennedy, Robert T; Shimshek, Derya R; Varani, Katia; Bubacco, Luigi; Greggio, Elisa; Morari, Michele
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
2018 Arcuri, Ludovico; Novello, Salvatore; Frassineti, Martina; Mercatelli, Daniela; Pisano', Clarissa Anna; Morella, Ilaria; Fasano, Stefania; Journigan, Blair V; Meyer, Michael E; Polgar, Willma E; Brambilla, Riccardo; Zaveri, Nurulain T; Morari, Michele
Autophagy and LRRK2 in the Aging Brain
2019 Albanese, F.; Novello, S.; Morari, M.
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
2018 Tozzi, A; Durante, V; Bastioli, G; Mazzocchetti, P; Novello, S; Mechelli, A; Morari, M; Costa, C; Mancini, A; Di Filippo, M; Calabresi, P
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice
2022 Domenicale, Chiara; Mercatelli, Daniela; Albanese, Federica; Novello, Salvatore; Vincenzi, Fabrizio; Varani, Katia; Morari, Michele
Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse
2021 Regoni, M.; Zanetti, L.; Comai, S.; Mercatelli, D.; Novello, S.; Albanese, F.; Croci, L.; Consalez, G. G.; Ciammola, A.; Valtorta, F.; Morari, M.; Sassone, J.
G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice
2018 Novello, S; Arcuri, L; Dovero, S; Dutheil, N; Shimshek, Dr; Bezard, E; Morari, M
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
2020 Bourdenx, M.; Nioche, A.; Dovero, S.; Arotcarena, M. -L.; Camus, S.; Porras, G.; Thiolat, M. -L.; Rougier, N. P.; Prigent, A.; Aubert, P.; Bohic, S.; Sandt, C.; Laferriere, F.; Doudnikoff, E.; Kruse, N.; Mollenhauer, B.; Novello, S.; Morari, M.; Leste-Lasserre, T.; Damas, I. T.; Goillandeau, M.; Perier, C.; Estrada, C.; Garcia-Carrillo, N.; Recasens, A.; Vaikath, N. N.; El-Agnaf, O. M. A.; Herrero, M. T.; Derkinderen, P.; Vila, M.; Obeso, J. A.; Dehay, B.; Bezard, E.
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity
2022 Novello, S.; Mercatelli, D.; Albanese, F.; Domenicale, C.; Brugnoli, A.; D'Aversa, E.; Vantaggiato, S.; Dovero, S.; Murtaj, V.; Presotto, L.; Borgatti, M.; Shimshek, D. R.; Bezard, E.; Moresco, R. M.; Belloli, S.; Morari, M.
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance
2021 Sarti, Alba Clara; Vultaggio-Poma, Valentina; Falzoni, Simonetta; Missiroli, Sonia; Giuliani, Anna Lisa; Boldrini, Paola; Bonora, Massimo; Faita, Francesco; Di Lascio, Nicole; Kusmic, Claudia; Solini, Anna; Novello, Salvatore; Morari, Michele; Rossato, Marco; Wieckowski, Mariusz R; Giorgi, Carlotta; Pinton, Paolo; Di Virgilio, Francesco
NOP receptor ligands and Parkinson’s disease
2019 Mercatelli, D.; Pisano, C. A.; Novello, S.; Morari, M.
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity
2020 Regoni, M.; Cattaneo, S.; Mercatelli, D.; Novello, S.; Passoni, A.; Bagnati, R.; Davoli, E.; Croci, L.; Consalez, G. G.; Albanese, F.; Zanetti, L.; Passafaro, M.; Serratto, G. M.; Di Fonzo, A.; Valtorta, F.; Ciammola, A.; Taverna, S.; Morari, M.; Sassone, J.
Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia
2018 Morari, Michele; Brugnoli, Alberto; Pisanò, Clarissa Anna; Novello, Salvatore; Caccia, Carla; Melloni, Elsa; Padoani, Gloria; Vailati, Silvia; Sardina, Marco
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease
2020 Pisano, C. A.; Brugnoli, A.; Novello, S.; Caccia, C.; Keywood, C.; Melloni, E.; Vailati, S.; Padoani, G.; Morari, M.
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia
2018 Gardoni, F; Morari, M; Kulisevsky, J; Brugnoli, Alberto; Novello, S; Pisanò, CLARISSA ANNA; Caccia, C; Mellone, M; Melloni, E; Padoani, G; Sosti, V; Vailati, S; Keywood, C
STUDY ON THE INTERACTION BETWEEN LRRK2 G2019S MUTATION AND PARKINSONIAN RISK FACTORS
2019 Novello, Salvatore
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice | 2017 | Longo, Francesco; Mercatelli, Daniela; Novello, Salvatore; Arcuri, Ludovico; Brugnoli, Alberto; V...incenzi, Fabrizio; Russo, Isabella; Berti, Giulia; Mabrouk, Omar Sharif; Kennedy, Robert T; Shimshek, Derya R; Varani, Katia; Bubacco, Luigi; Greggio, Elisa; Morari, Michele | |
| Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists | 2018 | Arcuri, Ludovico; Novello, Salvatore; Frassineti, Martina; Mercatelli, Daniela; Pisano', Clarissa... Anna; Morella, Ilaria; Fasano, Stefania; Journigan, Blair V; Meyer, Michael E; Polgar, Willma E; Brambilla, Riccardo; Zaveri, Nurulain T; Morari, Michele | |
| Autophagy and LRRK2 in the Aging Brain | 2019 | Albanese, F.; Novello, S.; Morari, M. | |
| Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease | 2018 | Tozzi, A; Durante, V; Bastioli, G; Mazzocchetti, P; Novello, S; Mechelli, A; Morari, M; Costa, C;... Mancini, A; Di Filippo, M; Calabresi, P | |
| Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice | 2022 | Domenicale, Chiara; Mercatelli, Daniela; Albanese, Federica; Novello, Salvatore; Vincenzi, Fabriz...io; Varani, Katia; Morari, Michele | |
| Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse | 2021 | Regoni, M.; Zanetti, L.; Comai, S.; Mercatelli, D.; Novello, S.; Albanese, F.; Croci, L.; Consale...z, G. G.; Ciammola, A.; Valtorta, F.; Morari, M.; Sassone, J. | |
| G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice | 2018 | Novello, S; Arcuri, L; Dovero, S; Dutheil, N; Shimshek, Dr; Bezard, E; Morari, M | |
| Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates | 2020 | Bourdenx, M.; Nioche, A.; Dovero, S.; Arotcarena, M. -L.; Camus, S.; Porras, G.; Thiolat, M. -L.;... Rougier, N. P.; Prigent, A.; Aubert, P.; Bohic, S.; Sandt, C.; Laferriere, F.; Doudnikoff, E.; Kruse, N.; Mollenhauer, B.; Novello, S.; Morari, M.; Leste-Lasserre, T.; Damas, I. T.; Goillandeau, M.; Perier, C.; Estrada, C.; Garcia-Carrillo, N.; Recasens, A.; Vaikath, N. N.; El-Agnaf, O. M. A.; Herrero, M. T.; Derkinderen, P.; Vila, M.; Obeso, J. A.; Dehay, B.; Bezard, E. | |
| In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity | 2022 | Novello, S.; Mercatelli, D.; Albanese, F.; Domenicale, C.; Brugnoli, A.; D'Aversa, E.; Vantaggiat...o, S.; Dovero, S.; Murtaj, V.; Presotto, L.; Borgatti, M.; Shimshek, D. R.; Bezard, E.; Moresco, R. M.; Belloli, S.; Morari, M. | |
| Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance | 2021 | Sarti, Alba Clara; Vultaggio-Poma, Valentina; Falzoni, Simonetta; Missiroli, Sonia; Giuliani, Ann...a Lisa; Boldrini, Paola; Bonora, Massimo; Faita, Francesco; Di Lascio, Nicole; Kusmic, Claudia; Solini, Anna; Novello, Salvatore; Morari, Michele; Rossato, Marco; Wieckowski, Mariusz R; Giorgi, Carlotta; Pinton, Paolo; Di Virgilio, Francesco | |
| NOP receptor ligands and Parkinson’s disease | 2019 | Mercatelli, D.; Pisano, C. A.; Novello, S.; Morari, M. | |
| Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity | 2020 | Regoni, M.; Cattaneo, S.; Mercatelli, D.; Novello, S.; Passoni, A.; Bagnati, R.; Davoli, E.; Croc...i, L.; Consalez, G. G.; Albanese, F.; Zanetti, L.; Passafaro, M.; Serratto, G. M.; Di Fonzo, A.; Valtorta, F.; Ciammola, A.; Taverna, S.; Morari, M.; Sassone, J. | |
| Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia | 2018 | Morari, Michele; Brugnoli, Alberto; Pisanò, Clarissa Anna; Novello, Salvatore; Caccia, Carla; Mel...loni, Elsa; Padoani, Gloria; Vailati, Silvia; Sardina, Marco | |
| Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease | 2020 | Pisano, C. A.; Brugnoli, A.; Novello, S.; Caccia, C.; Keywood, C.; Melloni, E.; Vailati, S.; Pado...ani, G.; Morari, M. | |
| Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia | 2018 | Gardoni, F; Morari, M; Kulisevsky, J; Brugnoli, Alberto; Novello, S; Pisanò, CLARISSA ANNA; Cacci...a, C; Mellone, M; Melloni, E; Padoani, G; Sosti, V; Vailati, S; Keywood, C | |
| STUDY ON THE INTERACTION BETWEEN LRRK2 G2019S MUTATION AND PARKINSONIAN RISK FACTORS | 2019 | Novello, Salvatore |